Climate Emergency, Psychoanalysis, and Radical Ethics - Donna Orange, PhD, PsyD (Live)
FRIDAY NIGHT GUEST LECTURE SERIES 2023-24
Continuing education to follow
Despite a tendency to avoid the warnings, times of crisis summon clinicians to emerge from comfortable consulting rooms. Daily engaged with human suffering, they now face the inextricably bound together crises of global warming and massive social injustices. Considering historical and emotional causes of climate unconsciousness and of compulsive consumerism, we argue that only a radical ethics of responsibility to be “my other’s keeper” will truly wake us up to climate change and bring psychoanalysts to actively take on responsibilities. Linking climate justice to radical ethics by way of psychoanalysis, we here consider relevant aspects of psychoanalytic expertise, referring to work on trauma, mourning, and the transformation of trouble into purpose.
Educated in philosophy, clinical psychology and psychoanalysis, Donna Orange, PhD, PsyD teaches at NYU Postdoc (New York); IPSS (Institute for the Psychoanalytic Study of Subjectivity, New York); and in private study groups. She also offers clinical consultation/supervision in these institutes and beyond. Recent books are Thinking for Clinicians: Philosophical Resources for Contemporary Psychoanalysis and the Humanistic Psychotherapies(2010), and The Suffering Stranger: Hermeneutics for Everyday Clinical Practice(2011),Nourishing the Inner Life of Clinicians and Humanitarians: The Ethical Turn in Psychoanalysis,and Climate Crisis, Psychoanalysis, and Radical Ethics (2016), and most recently, Psychoanalysis, History, and Radical Ethics: Learning to Hear (2020). 2021 Visiting Professor of Phenomenology, Duquesne University
Austen Riggs Center Inc. adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. All those at Austen Riggs Center involved in the planning of this activity, including the presenter(s) listed above, report they have no relevant financial relationships with an ineligible company*.
The views and opinions expressed in this presentation are those of the presenter(s) and do not necessarily represent the official policy or position of the Austen Riggs Center.
* An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.